| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a693232b92910547c898db10feb83fef |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-53 |
| filingDate |
2017-02-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2018-01-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dfa9dda2b25962602a9edfacf38c23b0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5d711620feed595719fab92b57544442
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ed0b0ca4e604b35ae11c9992ab98cdfb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_54d04e00953e8e102b3983873d4cf895
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_03c219df41c51f718fdbe0da3b3bc044
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e151fc8af5d47822fede24acd4e213d5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b94e45bd9719709109a08fabc2123e5d |
| publicationDate |
2018-01-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
AU-2017200886-B2 |
| titleOfInvention |
PDE9 inhibitors with imidazo triazinone backbone |
| abstract |
PDE9 INHIBITORS WITH IMIDAZO TRIAZINONE BACKBONE This invention is directed to compounds, which are PDE9 enzyme inhibitors. The invention provides a pharmaceutical composition comprising a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. The present invention also provides processes for the preparation of the compounds of formula (I). The present invention further provides a method of treating a subject suffering from a neurodegenerative disorder comprising administering to the subject a therapeutically effective amount of a compound of formula (I). The present invention further provides a compound of formula (I) for use in a method of treating a subject suffering from a psychiatric disorder comprising administering to the subject ta therapeutically effective amount of a compound of formula (I). |
| priorityDate |
2012-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |